Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(S)-2-((2S,8S,11S,14S,17S,20S,26S)-26-amino-14-benzyl-8,11,20-tris(3-guanidinopropyl)-27-(1H-indol-3-yl)-2-isopropyl-17-methyl-4,7,10,13,16,19,22,25-octaoxo-3,6,9,12,15,18,21,24-octaazaheptacosanamido)-N-((6S,9S,18S,21S,24S,27S)-1,32-diamino-6-carbamoyl-9,18-bis(3-guanidinopropyl)-1,32-diimino-24-isobutyl-21-methyl-8,11,14,17,20,23,26-heptaoxo-2,7,10,13,16,19,22,25,31-nonaazadotriacontan-27-yl)-5-guanidinopentanamide
ID: ALA4785764
Chembl Id: CHEMBL4785764
PubChem CID: 162666925
Max Phase: Preclinical
Molecular Formula: C93H160N44O18
Molecular Weight: 2182.59
Molecule Type: Unknown
Associated Items: